Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):44–50. doi: 10.1097/QAI.0b013e3181fbcbf7

Figure 1b. Composite Genotype Sensitivity Scores (dGSS) for Second Regimen by Duration of Failure.

Figure 1b

Figure 1a Caption. Results were divided into tertiles of duration of failure (9.4 months); dGSS scores indicate the number of fully active drugs predicted using detected mutations and the standard second line regimen (didanosine, abacavir, and ritonavir boosted lopinavir). (http://hivdb.stanford.edu);11 bars are means +/− standard errors.